Hengrui Pharma repurchases 120,000 A shares for ESOP; treasury stock rises to 8.31 million

Bulletin Express

Jun 17

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a share buyback on 17 June 2026, aimed at its A-share Employee Stock Ownership Schemes (ESOP).

• Transaction details: 120,000 A shares were repurchased on the Shanghai Stock Exchange at prices between RMB 46.85 and RMB 46.88 per share, representing a volume-weighted average price of RMB 46.87. The aggregate consideration amounted to RMB 5.62 million.

• Impact on share capital: Following the repurchase, issued shares (excluding treasury shares) fell from 6,370.81 million to 6,370.69 million, a marginal 0.0019% reduction. Treasury shares increased to 8.31 million, keeping total issued shares unchanged at 6,379.00 million.

• Purpose and status: All 120,000 repurchased shares are held as treasury stock for the ESOP. No cancellations were reported.

• Compliance: The company confirmed the buyback was duly authorised by the board and conducted in accordance with all applicable listing rules, laws and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1176445493"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176445493\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176445493?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 17:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176445493","market":"us","top_or_hot":-1,"title":"Hengrui Pharma repurchases 120,000 A shares for ESOP; treasury stock rises to 8.31 million","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a share buyback on 17 June 2026, aimed at its A-share Employee Stock Ownership Schemes (ESOP).</p>\n<p>• Transaction details: 120,000 A shares were repurchased on the Shanghai Stock Exchange at prices between RMB 46.85 and RMB 46.88 per share, representing a volume-weighted average price of RMB 46.87. The aggregate consideration amounted to RMB 5.62 million.</p>\n<p>• Impact on share capital: Following the repurchase, issued shares (excluding treasury shares) fell from 6,370.81 million to 6,370.69 million, a marginal 0.0019% reduction. Treasury shares increased to 8.31 million, keeping total issued shares unchanged at 6,379.00 million.</p>\n<p>• Purpose and status: All 120,000 repurchased shares are held as treasury stock for the ESOP. No cancellations were reported.</p>\n<p>• Compliance: The company confirmed the buyback was duly authorised by the board and conducted in accordance with all applicable listing rules, laws and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma repurchases 120,000 A shares for ESOP; treasury stock rises to 8.31 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma repurchases 120,000 A shares for ESOP; treasury stock rises to 8.31 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-17 17:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a share buyback on 17 June 2026, aimed at its A-share Employee Stock Ownership Schemes (ESOP).</p>\n<p>• Transaction details: 120,000 A shares were repurchased on the Shanghai Stock Exchange at prices between RMB 46.85 and RMB 46.88 per share, representing a volume-weighted average price of RMB 46.87. The aggregate consideration amounted to RMB 5.62 million.</p>\n<p>• Impact on share capital: Following the repurchase, issued shares (excluding treasury shares) fell from 6,370.81 million to 6,370.69 million, a marginal 0.0019% reduction. Treasury shares increased to 8.31 million, keeping total issued shares unchanged at 6,379.00 million.</p>\n<p>• Purpose and status: All 120,000 repurchased shares are held as treasury stock for the ESOP. No cancellations were reported.</p>\n<p>• Compliance: The company confirmed the buyback was duly authorised by the board and conducted in accordance with all applicable listing rules, laws and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1176445493","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176445493","pubTimestamp":1781687221,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a share buyback on 17 June 2026, aimed at its A-share Employee Stock Ownership Schemes (ESOP). • Transaction details: 120,000 A...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药回购12万股A股用于ESOP；库存股升至831万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a share buyback on 17 June 2026, aimed at its A-share Employee Stock Ownership Schemes (ESOP).\n• Transaction details: 120,000 A shares were repurchased on the Shanghai Stock Exchange at prices between RMB 46.85 and RMB 46.88 per share, representing a volume-weighted average price of RMB 46.87. The aggregate consideration amounted to RMB 5.62 million.\n• Impact on share capital: Following the repurchase, issued shares (excluding treasury shares) fell from 6,370.81 million to 6,370.69 million, a marginal 0.0019% reduction. Treasury shares increased to 8.31 million, keeping total issued shares unchanged at 6,379.00 million.\n• Purpose and status: All 120,000 repurchased shares are held as treasury stock for the ESOP. No cancellations were reported.\n• Compliance: The company confirmed the buyback was duly authorised by the board and conducted in accordance with all applicable listing rules, laws and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}